Informationen:
Fehler:
ID
18491
Beschreibung
Phase II Iressa + Irradiation Followed by Chemo in NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT00333294
Link
https://clinicaltrials.gov/show/NCT00333294
Stichworte
Versionen (1)
- 07.11.16 07.11.16 -
Hochgeladen am
7. November 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Non-Small Cell Lung Cancer NCT00333294
Eligibility Non-Small Cell Lung Cancer NCT00333294
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Non-Small Cell Lung Cancer NCT00333294
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Informed Consent
Item
signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Age
Item
18 to 75 years inclusive.
boolean
C0001779 (UMLS CUI [1])
Measurable Disease Quantity | Non-Small Cell Lung Carcinoma Inoperable | TNM clinical staging
Item
at least one measurable lesions histologically confirmed inoperable stage iii nsclc.
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0007131 (UMLS CUI [2,1])
C0205187 (UMLS CUI [2,2])
C3258246 (UMLS CUI [3])
C1265611 (UMLS CUI [1,2])
C0007131 (UMLS CUI [2,1])
C0205187 (UMLS CUI [2,2])
C3258246 (UMLS CUI [3])
WHO performance status scale
Item
who performance status of 0 to 2 inclusive.
boolean
C1298650 (UMLS CUI [1])
Pulmonary function | Dose Volume Histogram Pulmonary
Item
adequate pulmonary function, pulmonary dose volume histogram less than or equal to 40
boolean
C0231921 (UMLS CUI [1])
C3827011 (UMLS CUI [2,1])
C2709248 (UMLS CUI [2,2])
C3827011 (UMLS CUI [2,1])
C2709248 (UMLS CUI [2,2])
Life Expectancy
Item
life expectancy of at least 6 months.
boolean
C0023671 (UMLS CUI [1])
Contraceptive methods Effective
Item
using secure contraceptives precautions.
boolean
C0700589 (UMLS CUI [1,1])
C1280519 (UMLS CUI [1,2])
C1280519 (UMLS CUI [1,2])
cancer treatment Non-Small Cell Lung Carcinoma
Item
any previous anti cancer therapy for nsclc.
boolean
C0920425 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,2])
severe allergy products
Item
known severe hypersensitivity to these products
boolean
C2945656 (UMLS CUI [1,1])
C1514468 (UMLS CUI [1,2])
C1514468 (UMLS CUI [1,2])
Interstitial Lung Disease Evidence of
Item
any evidence of clinically active interstitial lung disease
boolean
C0206062 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,2])
Malignant Neoplasms | Neoplasm Metastasis Symptomatic
Item
other co-existing malignancies, symptomatic metastases.
boolean
C0006826 (UMLS CUI [1])
C0027627 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
Blood test abnormal
Item
abnormal blood test
boolean
C0854146 (UMLS CUI [1])
Weight decreased Percentage
Item
weight loss of over 15% in the 3 months before the start of the study.
boolean
C1262477 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,2])
Drugs, Non-Prescription | Investigational New Drugs
Item
treatment with a non-approved or investigational drug within 30 days before day 1 of study treatment.
boolean
C0013231 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0013230 (UMLS CUI [2])